Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Atractylenolide III (ICodonolactone) may have therapeutic potential in treating homocysteine-mediated cognitive impairment and neuronal injury. Atractylenolide III is a potential candidate for the treatment of human lung carcinoma by inducing the release of cytochrome c, upregulating the expression of Bax and translocating apoptosis-inducing factor.
説明 | Atractylenolide III (ICodonolactone) may have therapeutic potential in treating homocysteine-mediated cognitive impairment and neuronal injury. Atractylenolide III is a potential candidate for the treatment of human lung carcinoma by inducing the release of cytochrome c, upregulating the expression of Bax and translocating apoptosis-inducing factor. |
植物由来 |
別名 | ICodonolactone, 8β-Hydroxyasterolide |
分子量 | 248.32 |
分子式 | C15H20O3 |
CAS No. | 73030-71-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Chloroform, Dichloromethane, Ethyl Acetate, Acetone: Soluble
DMSO: 46 mg/mL(185.2 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Atractylenolide III 73030-71-4 Apoptosis Inhibitor ICodonolactone 8β-Hydroxyasterolide 8b-Hydroxyasterolide inhibit 8beta-Hydroxyasterolide inhibitor